when were glp 1 drugs invented Discovery of GLP-1–Based for the Treatment of Obesity GLP-1R Agonists for Weight Loss
Description
Non-insulin antidiabetic agents and lung cancer risk in drug-naive patients with type 2 diabetes mellitus: a nationwide retrospective cohort study
Weight loss was similar in patients on CSII, with a mean weight loss of 6.3 kg (55)
No diabetes medications were added.
Secher, Jelsing, Baqueror)
All this is to say that we would expect the prevalence of coverage of GLP-1s in the individual market to be quite low compared to the self-insured employer market
